Company founded in Madrid.

First logo.

Refoundation and relocation of the registered office to Amer.

First vaccines approved on the market: PORCIPRA® (swine), HIPRAVIAR® BPL2 (poultry) and TOXIPRA® (ruminants).

Logo update.

First product developed at Amer.

Publication of the first product catalogue with a new design for each line.

Opening of the foot and mouth disease plant for the manufacture of vaccines against this virus.

Construction of the CEYC (Animal Experimentation and Control Centre).

Participation in the first Expoavícola national trade fair.

HIPRAGUMBORO® (poultry). Live vaccine, against Gumboro disease.

Holding of the first general sales convention.

Advertisement posted in an industry journal.

Inauguration of the Diagnostics Department (DIAGNOS).

Scientific publications of the times.

Aerial view of the company Headquarters.

HIPRAGUMBORO® CH/80 (poultry). Cloned live vaccine against Gumboro disease, oral freeze-dried tablet.

MIXOHIPRA® FSA (rabbits). Live heterologous vaccine against myxomatosis, lyophilisate for injection.

Conveyor belt on the packaging line.

Array of current product range.

The number of employees reaches 100.

AUSKIPRA® GN (swine). Live vaccine against Aujeszky’s disease gE negative strain, lyophilisate for injection.

Construction of the CIAMER-1 (Amer Immunological Product Centre 1) biologics production plant.

HIPRABOVIS® 4 (ruminants). Combined vaccine against IBR, PI3, BVD and BRS viruses, in injectable suspension.

Change in shareholder structure.

GENTAMOX® (pharmaceutical). Amoxicillin and gentamicin, in injectable suspension.

Definition of the HIPRA 2000 strategic project.

HIPRALONA® ENROS-S (pharmaceutical). Enrofloxacin, oral solution.

First ads published in world-renowned journals: Pig International and Poultry International.

HIPRAVIAR® SHS (poultry). Live vaccine against turkey rhinotracheitis and swollen head syndrome, in oculonasal freeze-dried tablet.

HIPRAVIAR® TRT (poultry). Inactivated vaccine against turkey rhinotracheitis and swollen head syndrome, in injectable emulsion.

Participation in the first international trade fair, VIV Europe-Utrecht.

Cuniculture product advertisement published in press.

Construction of the VIF1 (Inactivated Vaccines and Drugs -1) production plant.

Array of current product range.

Construction of the CIAMER-2 (Amer Immunological Product Centre 2) biologics production plant.

Creation of the first subsidiary: HIPRA URUGUAY.

First Good Manufacturing Practice (GMP) Certificate obtained.

HIPRASUIS® GLÄSSER (swine). Inactivated vaccine against Glässer’s disease, in injectable suspension.

Closure of the foot and mouth disease plant.

HIPRADOXI® S (pharmaceutical). Doxycycline, oral solution.

Aerial view of the company Headquarters.

Launch of the first website.

Creation of the HIPRA ANDINA and HIPRA PORTUGAL subsidiaries.

AVISAN SECURE® (poultry). Inactivated vaccine against avian salmonellosis, emulsion for injection.

Creation of the HIPRA BRASIL, HIPRA MÉXICO and HIPRA SOUTHERN AFRICA subsidiaries.

HIPRAGUMBORO® GM97 (poultry). Live vaccine against Gumboro disease GM97 strain, in oral freeze-dried tablet.

ICTHIOVAC® PD (aquaculture). Inactivated vaccine against pasteurellosis in gilthead sea bream, suspension for immersion.

Creation of the HIPRA PHILIPPINES subsidiary.

HIPRADOG 7 (dogs). Live vaccine against canine parvovirus infections, distemper, hepatitis, laryngotracheitis and tracheobronchitis, lyophilisate for injection, and inactivated vaccine against canine leptospirosis, suspension for injection.

Construction of the warehouse and R&D building (CADI).

Creation of the HIPRA CHINA subsidiary.

Logo update.

Celebration of 50 year anniversary (1954-2004) since the foundation of the company in Madrid.

Array of products of the times.

Creation of the HIPRA KOREA, HIPRA TÜRKIYE and HIPRA HELLAS subsidiaries.

HIPRABOVIS® SOMNI/Lkt (ruminants). Inactivated vaccine against pneumonia caused by Histophilus somni and Mannheimia haemolytica leukotoxoid, in injectable emulsion.

EFICUR® (pharmaceutical). Ceftiofur, solution for injection.

HIPRACOX® (poultry).
Live vaccine against coccidiosis in chickens, oral suspension spray.

Construction of the coccidiosis vaccine plant.

Construction of the Lloret Salvatge 1 oocyst plant.

Acquisition of IRFA in Brazil.

SELECTAN® (pharmaceutical). Florfenicol, solution for injection.

The number of employees reaches 500.

Creation of the HIPRA FRANCE, HIPRA MALAYSIA and HIPRA POLSKA subsidiaries.

New vision: To become the reference in prevention for animal health with differential products. Some pharmaceutical products are discontinued.

STARTVAC® (ruminants). Polyvalent inactivated vaccine against bovine mastitis, in injectable emulsion.

SUISENG® (swine). Inactivated vaccine against neonatal colibacillosis and Clostridium infections in swine, in injectable suspension.

Creation of the HIPRA DEUTSCHLAND, HIPRA UK, HIPRA ITALIA and HIPRA BELGIUM subsidiaries.

Headquarters employees form a “Human H”.

HIPRA enters the world Top 10 of biologics sellers.

Creation of the HIPRA USA, HIPRA RUSSIA and HIPRA ARGENTINA subsidiaries.

HIPRABOVIS® IBR MARKER LIVE (ruminants). Live vaccine (double gene deleted gE-/tk-) against IBR virus, in injectable freeze-dried tablet.

RHINISENG® (swine). Inactivated vaccine, progressive and non progressive swine atrophic rhinitis, in injectable suspension.

HIPRAMIX-AMOXI (swine). Amoxicillin 5% medicated premix.

Creation of the HIPRA CANADA, HIPRA INDIA and HIPRA NETHERLANDS subsidiaries.

Creation of the HIPRA DENMARK, HIPRA JAPAN and HIPRA INDONESIA subsidiaries.

First celebration of HIPRA University course.

UNISTRAIN® PRRS (swine). Live vaccine against porcine reproductive and respiratory syndrome (PRRS), in injectable freeze-dried tablet.

Creation of the HIPRA VIETNAM and HIPRA COLOMBIA subsidiaries.

ERYSENG® PARVO (swine). Inactivated vaccine against porcine parvovirus and swine erysipelas, suspension for injection.

VIMCO® (ruminants). Inactivated vaccine against caprine and ovine mastitis, emulsion for injection.

The number of employees reaches 1,000.

Creation of the HIPRA THAILAND, HIPRA MOROCCO, HIPRA IRELAND and HIPRA ÖSTERREICH subsidiaries.

Launch of the Hipradermic® vaccination device.

Launch of the Hipraspray® vaccination device.

ERYSENG® PARVO/LEPTO (swine). Inactivated vaccine against swine erysipelas, parvovirosis and leptospirosis, in injectable suspension.

EVALON® (poultry). Live vaccine against avian coccidiosis, in oral suspension for spray.

Construction of the histovirus plant at CIAMER OEST.

Creation of the HIPRA UKRAINE subsidiary.

Closure of the POD plant.

Headquarters employees and subsidiary representatives form a “Human H”.

Construction of the CIAMER SUD (Amer Immunological Product Centre South) biologics production plant.

Opening of the dispatch warehouse at CIM La Selva.

Creation of the HIPRA TAIWAN and HIPRA SWEDEN subsidiaries.

VEPURED® (swine). Purified recombinant verotoxin 2e against edema disease, in suspension for injection.

The number of employees reaches 1,500.

114,000 sqm of land purchased in Aiguaviva.

Creation of the HIPRA SLOVENSKO and HIPRA CESKÁ REPUBLIKA subsidiaries.

Creation of the HIPRASTATS Department.

GUMBOHATCH® (poultry). IBD immune-complex vaccine against Infectious Bursal Disease, in injectable suspension.

UBAC® (ruminants). Subunit vaccine against mastitis caused by Streptococcus uberis, in injectable emulsion.

NASYM® (ruminants). Live vaccine against Bovine Respiratory Syncytial Virus (BRSV), in suspension for injection.

Launch of the Hipraject® vaccination device.

EVANT® (poultry). Live vaccine against avian coccidiosis in chickens, oral suspension spray.

INMEVA® (ruminants). Inactivated vaccine against Chlamydia abortus and Salmonella abortusovis in sheep, suspension for injection.

Logo update and creation of a secondary one.

Construction of the Lloret Salvatge 2 oocyst plant

Construction of the VIF2 (Inactivated Vaccines and Pharmaceuticals -2) production plant.

Opening of the Scientific Marketing Unit (SMU).

Creation of the HIPRA PAKISTAN subsidiary.

MHYOSPHERE® PCV ID (swine). The first intradermal needle-free vaccine against Mycoplasma hyopneumoniae and PCV2, all in one, in suspension for injection.

Closure of the Oral Liquids line.

The number of employees reaches 2,000.

EVANOVO® (poultry). Attenuated vaccine for coccidosis in broilers specifically developed to be administered by in ovo injection.

50-year anniversary (1971-2021) of refoundation in Amer.

First step towards human health with the development of a COVID-19 vaccine.

Acquisition of GoodGut.

SUISENG® Diff/A (swine). Inactivated vaccine against Clostridioides difficile and Clostridium perfringens type A infections in swine, in injectable suspension.

“Nonconformism” is added as a HIPRA value.